Wells Fargo’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-632
Closed -$4.97K 7062
2024
Q3
$4.97K Hold
632
﹤0.01% 5915
2024
Q2
$7.08K Hold
632
﹤0.01% 5813
2024
Q1
$8K Hold
632
﹤0.01% 5811
2023
Q4
$8.68K Hold
632
﹤0.01% 5866
2023
Q3
$7.13K Hold
632
﹤0.01% 5880
2023
Q2
$8.44K Sell
632
-1,500
-70% -$17.6K ﹤0.01% 5948
2023
Q1
$24.8K Hold
2,132
﹤0.01% 5556
2022
Q4
$25.6K Sell
2,132
-350
-14% -$4.54K ﹤0.01% 5152
2022
Q3
$32K Buy
2,482
+1,100
+80% +$13.5K ﹤0.01% 5152
2022
Q2
$19K Buy
1,382
+750
+119% +$9.95K ﹤0.01% 5470
2022
Q1
$9K Sell
632
-330
-34% -$4.36K ﹤0.01% 6295
2021
Q4
$14K Sell
962
-100
-9% -$1.38K ﹤0.01% 6433
2021
Q3
$14K Buy
1,062
+100
+10% +$1.35K ﹤0.01% 6084
2021
Q2
$14K Buy
962
+330
+52% +$4.66K ﹤0.01% 6029
2021
Q1
$6K Buy
+632
New +$5.3K ﹤0.01% 6445

Other funds holding BIOX

Wells Fargo's BIOX Position: Q4 2024 in Review

Wells Fargo sold out of Bioceres Crop Solutions (BIOX) in Q4 2024, closing a stake of 632 shares — an estimated $4.97K sold.

Wells Fargo first reported a position in BIOX in Q1 2021 and held it in 15 quarters. The position peaked at $32K in Q3 2022. 43 funds tracked by Wall St. Rank hold BIOX as of Q4 2024.

  • Wells Fargo reported no remaining Bioceres Crop Solutions position as of Q4 2024 after selling out during the quarter.
  • Wells Fargo sold 632 Bioceres Crop Solutions shares in Q4 2024, an estimated $4.97K.
  • Wells Fargo first reported a position in Bioceres Crop Solutions in Q1 2021 and held it in 15 quarters.
  • Wells Fargo's Bioceres Crop Solutions position peaked at $32K in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.